Literature DB >> 31997563

Find the Missing Millions: Malaysia's experience with nationwide hepatitis C screening campaign in the general population.

Rosaida Md Said1, Rozainanee Mohd Zain2, Huan-Keat Chan3, Shahrul Aiman Soelar3, Norhayati Rusli4, Nazrila Hairizan Nasir5, Rozita Zakaria6, Muhammad Radzi Abu Hassan7.   

Abstract

Approximately 2.5% of the Malaysian population is currently living with hepatitis C virus (HCV) infection. Yet, the public awareness of the disease is limited and under-screening remains a major challenge. With the support of international non-for-profit organizations, the Ministry of Health in Malaysia recently launched a one-week nationwide hepatitis C screening campaign in conjunction with the World Hepatitis Day. For the first time, the rapid diagnostic test (RDT) for HCV screening was introduced in public health institutions. This campaign involved 49 hospitals and 38 health clinics across the country, targeting the adult general population with unknown HCV infection status. Of the 11 382 participants undergoing the RDT, 1.9% were found to be positive for hepatitis C antibody (anti-HCV) and were referred to on-site medical departments or nearby hospitals for confirmatory testing and treatment. Men, the Malay ethnic group, intranasal and injection drug users and ex-prisoners were shown to have higher odds of being positive for anti-HCV. In addition to serving as a model to educate the general population about the disease, this campaign demonstrates the feasibility of decentralizing HCV screening, particularly by promoting the use of RDT, and linking the HCV-infected patients to care in Malaysia.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  Malaysia; diagnostic screening programmes; hepatitis C; point-of-care testing

Mesh:

Substances:

Year:  2020        PMID: 31997563     DOI: 10.1111/jvh.13267

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  4 in total

1.  Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.

Authors:  Hsu-Heng Yen; Pei-Yuan Su; I-L Ing Liu; Ya-Huei Zeng; Siou-Ping Huang; Yu-Chun Hsu; Po-Ke Hsu; Yang-Yuan Chen
Journal:  BMC Gastroenterol       Date:  2021-05-08       Impact factor: 3.067

2.  Barriers to scaling up hepatitis C treatment in Malaysia: a qualitative study with key stakeholders.

Authors:  Huan-Keat Chan; Mohamed Azmi Hassali; Noor Syahireen Mohammed; Azlina Azlan; Muhammad Radzi Abu Hassan
Journal:  BMC Public Health       Date:  2022-02-21       Impact factor: 3.295

3.  A quasi-randomised controlled trial of online distribution of home-based hepatitis C self-testing for key populations in Malaysia: a study protocol.

Authors:  Sonjelle Shilton; Xiaohui Sem; Huan-Keat Chan; Han Yang Chung; Anu Karunanithy; Jessica Markby; Po-Lin Chan; Niklas Luhmann; Cheryl Johnson; Pamela Nabeta; Nazrila Hairizan Bt Nasir; Stefano Ongarello; Elena Ivanova Reipold; Muhammad Radzi Abu Hassan
Journal:  Trials       Date:  2022-04-12       Impact factor: 2.279

4.  Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study.

Authors:  Jessica Markby; Sonjelle Shilton; Xiaohui Sem; Huan Keat Chan; Rosaida Md Said; Sasikala Siva; Zalwani Zainuddin; Norasiah Abu Bakar; Haniza Omar; Ryan Jose Iii Ruiz; Mary Gaeddert; Alexander Tyshkovskiy; Madeline Adee; Jagpreet Chhatwal; Suresh Kumar; Jean-Michel Piedagnel; Rozainanee Mohd Zain; Caroline Menétrey; Fazidah Yuswan; Nazrila Hairizan Nasir; Isabelle Andrieux-Meyer; Fatanah Ismail; Rozita Zakaria; Ruziaton Hasim; Shahnaz Murad; Philippa Easterbrook; Muhammad Radzi Abu Hassan
Journal:  BMJ Open       Date:  2021-12-24       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.